Lacuna K, Bose S, Ingham M, Schwartz G. Therapeutic advances in leiomyosarcoma. Front Oncol. 2023;13:1149106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie W, Ning L, Huang Y, Liu Y, Zhang W, Hu Y, et al. Statin use and survival outcomes in endocrine-related gynecologic cancers: a systematic review and meta-analysis. Oncotarget. 2017;8:41508–17.

Article  PubMed  PubMed Central  Google Scholar 

Feng CH, Miller CM, Tenney ME, Lee NK, Yamada SD, Hasan Y. Statin use significantly improves overall survival in high-grade endometrial cancer. Int J Gynecol Cancer. 2016;26:1642–9.

Article  PubMed  Google Scholar 

Wang KH, Liu CH, Ding DC. Statins as repurposed drugs in gynecological cancer: a review. Int J Mol Sci. 2022;23:13937.

Clendening JW, Pandyra A, Boutros PC, El Ghamrasni S, Khosravi F, Trentin GA, et al. Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci USA. 2010;107:15051–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mullen PJ, Yu R, Longo J, Archer MC, Penn LZ. The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer. 2016;16:718–31.

Article  CAS  PubMed  Google Scholar 

Zhou W, Liu H, Yuan Z, Zundell J, Towers M, Lin J, et al. Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis. Cancer Cell. 2023;41:740–56.e10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang EH, Johnson LA, Eaton K, Hynes MJ, Carpentino JE, Higgins PD. Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice. Dig Dis Sci. 2010;55:3086–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, et al. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol. 2014;16:357–66.

Article  CAS  PubMed  Google Scholar 

Guerra B, Recio C, Aranda-Tavío H, Guerra-Rodríguez M, García-Castellano JM, Fernández-Pérez L. The mevalonate pathway, a metabolic target in cancer therapy. Front Oncol. 2021;11:626971.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schointuch MN, Gilliam TP, Stine JE, Han X, Zhou C, Gehrig PA, et al. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer. Gynecol Oncol. 2014;134:346–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen Z, Li S, Sheng B, Shen Q, Sun LZ, Zhu H, et al. The role of atorvastatin in suppressing tumor growth of uterine fibroids. J Transl Med. 2018;16:53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.

Article  CAS  PubMed  Google Scholar 

Sun J, Belke D, Gui Y, Chen YX, Zhou S, Zheng XL. Polo-like kinase 4 inhibitor CFI-400945 inhibits carotid arterial neointima formation but increases atherosclerosis. Cell Death Discov. 2023;9:49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26:1367–72.

Article  CAS  PubMed  Google Scholar 

Gene Ontology Consortium; Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, et al. The Gene Ontology knowledgebase in 2023. Genetics. 2023;224:iyad031.

Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353–D61.

Article  CAS  PubMed  Google Scholar 

Holm A, Graus MS, Wylie-Sears J, Tan JWH, Alvarez-Harmon M, Borgelt L, et al. An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma. J Clin Invest. 2025;135:e179782.

Pan Q, Zhong S, Wang H, Wang X, Li N, Li Y, et al. The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability. Mol Cell. 2021;81:2736–51.e8.

Article  CAS  PubMed  Google Scholar 

Kusama T, Mukai M, Tatsuta M, Nakamura H, Inoue M. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho. Int J Oncol. 2006;29:217–23.

Zhong WB, Liang YC, Wang CY, Chang TC, Lee WS. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling. Endocr Relat Cancer. 2005;12:615–29.

Baranyi M, Hegedus B, Molnar E, Tovari J, Randelovic I, Perczel A, et al. Farnesyltransferase inhibitors have antitumoral effects in mutant KRAS containing cancer cells in preclinical models. Magy Onkol. 2023;67:223–35.

PubMed  Google Scholar 

Mangelinck A, Habel N, Mohr A, Gaspar N, Stefanovska B, Fromigue O. Synergistic anti-tumor effect of simvastatin combined to chemotherapy in osteosarcoma. Cancers (Basel). 2021;13:5869.

Warita K, Ishikawa T, Sugiura A, Tashiro J, Shimakura H, Hosaka YZ, et al. Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-beta-treated epithelial cancer cells. Sci Rep. 2021;11:12763.